⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2182183 | 1.00 | — | — | |
| SCHEMBL1081706 | 1.00 | — | — | |
| SCHEMBL6573684 | 1.00 | — | — | |
| SCHEMBL3830467 | 1.00 | — | — | |
| SCHEMBL2033291 | 1.00 | — | — | |
| SCHEMBL26611997 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL7701941 | 0.98 | CYP2C19 (0.46) | — | |
| Hydrochloric Acid SCHEMBL7701945 | 0.98 | CYP2C19 (0.46) | — | |
| Hydrochloric Acid SCHEMBL21874191 | 0.98 | CYP2C19 (0.46) | — | |
| Hydrochloric Acid SCHEMBL14893315 | 0.98 | CYP2C19 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140155371-A1 | MULTICOMPONENT CRYSTALLINE SYSTEM OF EZETIMIBE AND PROLINE | BASF SE (DE) | 2014-06-05 | — | — | US | claimed |
| WO-2013014604-A1 | MULTICOMPONENT CRYSTALLINE SYSTEM OF EZETIMIBE AND PROLINE | BASF SE (DE) | 2013-01-31 | — | — | WO | claimed |
| WO-2011085393-A1 | STABLE INSULIN FORMULATIONS AND METHODS OF MAKING AND USING THEREOF | GENECOPOEIA, INC. (US) | 2011-07-14 | — | — | WO | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
| EP-3922634-B1 | SUBSTITUTED PYRROLIZINE COMPOUNDS AND USES THEREOF | GILEAD SCIENCES INC (US) | 2023-10-25 | — | — | EP | disclosed |
| US-20230270719-A1 | SUBSTITUTED PYRROLIZINE COMPOUNDS AND USES THEREOF | GILEAD SCIENCES, INC. | 2023-08-31 | — | — | US | disclosed |
| CN-116171280-A | Casein kinase 1 delta modulators | 詹森药业有限公司 | 2023-05-26 | — | — | CN | disclosed |
| WO-2023272720-A1 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS OF PD-L1 INTERACTIONS | Ascletis BioScience Co., Ltd (CN) | 2023-01-05 | — | — | WO | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| US-11472843-B2 | Malacidins and methods of use | THE ROCKEFELLER UNIVERSITY (US) | 2022-10-18 | — | — | US | disclosed |
| EP-3922634-A1 | SUBSTITUTED PYRROLIZINE COMPOUNDS AND USES THEREOF | Gilead Sciences, Inc. (US) | 2021-12-15 | — | — | EP | disclosed |
| US-20210251957-A1 | SUBSTITUTED PYRROLIZINE COMPOUNDS AND USES THEREOF | GILEAD SCIENCES, INC. | 2021-08-19 | — | — | US | disclosed |
| EP-0871656-A1 | NOVEL DOLASTATIN DERIVATIVES, THEIR PREPARATION AND USE | BASF AKTIENGESELLSCHAFT (DE) | 1998-10-21 | — | — | EP | disclosed |
| EP-0832104-A1 | NOVEL DOLASTATIN DERIVATIVES, THEIR PREPARATION AND USE | BASF AKTIENGESELLSCHAFT (DE) | 1998-04-01 | — | — | EP | disclosed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | disclosed |
| EP-0787010-A1 | AMIDINO AND GUANIDINO SUBSTITUTED INHIBITORS OF TRYPSIN-LIKE ENZYMES | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-06 | — | — | EP | disclosed |
| WO-1996040752-A1 | NOVEL DOLASTATIN DERIVATIVES, THEIR PREPARATION AND USE | BASF AKTIENGESELLSCHAFT (DE) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996040751-A1 | NOVEL DOLASTATIN DERIVATIVES, THEIR PREPARATION AND USE | BASF AKTIENGESELLSCHAFT (DE) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996012499-A1 | AMIDINO AND GUANIDINO SUBSTITUTED INHIBITORS OF TRYPSIN-LIKE ENZYMES | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-05-02 | — | — | WO | disclosed |
| US-5114920-A | BU-3292T antibiotics | BRISTOL-MYERS SQUIBB CO. (US) | 1992-05-19 | — | — | US | disclosed |